Furthermore, TET3 levels positively correlated with CDKN2B, ZIC2, and miR-196a levels, which appear to have anti-leukemic effects, thus suggesting a tumor suppressive role for TET3 in AML (158). Here, CDKN2B is linked to acute myeloid leukemia.